Evidence map›Paper›PMID 27754870›Full record

ArticleThe Journal of biological chemistry2016

Transgenic Expression of the Mitochondrial Chaperone TNFR-associated Protein 1 (TRAP1) Accelerates Prostate Cancer Development.

Sofia Lisanti, David S Garlick, Kelly G Bryant, Michele Tavecchio, Gordon B Mills, Yiling Lu, Andrew V Kossenkov, Louise C Showe, Lucia R Languino, Dario C Altieri

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. TRAP1 and its therapeutic potential.Bioorganic & medicinal chemistry letters · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Mitochondrial dynamics and metastasis.Cellular and molecular life sciences : CMLS · 2019
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Sofia LisantiFrom the Prostate Cancer Discovery and Development Program.
David S GarlickFrom the Prostate Cancer Discovery and Development Program.
Kelly G BryantFrom the Prostate Cancer Discovery and Development Program.
Michele TavecchioFrom the Prostate Cancer Discovery and Development Program.
Gordon B Millsthe Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, and.
Yiling Luthe Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, and.
Andrew V KossenkovCenter for Systems and Computational Biology, and.
Louise C ShoweCenter for Systems and Computational Biology, and.
Lucia R LanguinoFrom the Prostate Cancer Discovery and Development Program.
Dario C AltieriFrom the Prostate Cancer Discovery and Development Program, daltieri@wistar.org.
Prostate Cancer UK · GBThe University of Texas MD Anderson Cancer Center · USCenter for Systems Biology · USThe Wistar Institute · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
TRAINING PROGRAM IN BASIC CANCER RESEARCHT32CA009171 · NCI · WISTAR INSTITUTE · PI Alessandro Gardini · 1985 to 2026
$15.3M
Role of Runx2 in prostate tumorigenesis and metastasisP01CA140043 · NCI · WISTAR INSTITUTE · PI ALTIERI, DARIO C · 2010 to 2021
$12.2M
CONTROL OF APOPTOSIS IN CANCER BY SURVIVINR01CA078810 · NCI · YALE UNIVERSITY · PI ALTIERI, DARIO C · 1998 to 2017
$5.5M
INTEGRIN SIGNALING PATHWAYS IN PROSTATE CANCERR01CA089720 · NCI · YALE UNIVERSITY · PI LANGUINO, LUCIA R. · 2001 to 2014
$2.8M
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center LevelR50CA211199 · NCI · WISTAR INSTITUTE · PI Andrew V Kossenkov · 2016 to 2026
$1.6M
(PQC2) Plasticity Of The.PI3K Network In Early DormancyR01CA190027 · NCI · WISTAR INSTITUTE · PI ALTIERI, DARIO C · 2014 to 2016
$1.2M
NCI NIH HHS P01 CA140043NCI NIH HHS P30 CA010815NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA078810NCI NIH HHS R01 CA089720NCI NIH HHS R01 CA190027NCI NIH HHS R50 CA211199NCI NIH HHS T32 CA009171
6 · The paper itself

Abstract

Protein homeostasis, or proteostasis, is required for mitochondrial function, but its role in cancer is controversial. Here we show that transgenic mice expressing the mitochondrial chaperone TNFR-associated protein 1 (TRAP1) in the prostate develop epithelial hyperplasia and cellular atypia. When examined on a Pten

Indexed as

ApoptosisCell ProliferationAnimalsCell Line, TumorHSP90 Heat-Shock ProteinsHumansMaleMiceMice, TransgenicNeoplasm InvasivenessNeoplasm ProteinsProstateProstatic NeoplasmsHSP90 Heat-Shock ProteinsNeoplasm ProteinsTRAP1 protein, humanTRAP-1 protein, mousechaperoneheat shock protein 90 (Hsp90)mitochondriaprostate cancerprotein folding

Identifiers

PMID27754870
PMCPMC5122790
OpenAlexW2536268036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.